|From: johnsilver777 (Rep: 0)||Date: 02/15/2020 21:47|
|Forum: NeuroBo Pharmaceuticals - Msg #55||Thread #674123412 (Rec: 0) |
|IMMP could be new NRBO -Feb 19 major update on their Efti lead cancer drug|
Phase II study (TACTI-002) in metastatic non-small cell lung or head and neck carcinoma patients receiving eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab
Dr. Frederic Triebel who discovered LAG-3 is the Chief Scientific Officer & Chief Medical Officer of IMMP... looks like this new drug is his lifetime project coming to fruition
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.